This was in the AGM announcement, Take particular note of the...

This was in the AGM announcement, Take particular note of the LAST SENTENECE.

"on 19 July 2017 MCL, through its Director Andrew Kavasilas, applied to the Australian Government for a research cultivation licence, which is required prior to making an application for a permit to operate under that licence to grow cannabis varieties for medical cannabis research for the purposes of product development. As at the date of this Notice, the above permit has not been granted (and therefore the milestone relating to the conversion of the Performance Shares, as set out in paragraph (l) of Schedule 1 of this Notice, has not been achieved). From recent discussions with the Office of Drug Control, it is anticipated that, all things being equal, the grant of the permit will occur by October 2017."